earnings
confidence high
sentiment positive
materiality 0.90
BD Q3 adjusted EPS $3.50 beats, raises FY24 guidance; acquires Edwards Critical Care for $4.2B
BECTON DICKINSON & CO
2024-Q3 EPS reported
$4.49
revenue$14,741,000,000
- Revenue $4.99B as reported, $5.057B adjusted; organic revenue growth 5.2% YoY.
- GAAP diluted EPS $1.68 (+23.5% YoY); adjusted diluted EPS $3.50 (+18.2% YoY).
- Year-to-date free cash flow $2.2B, up over 100% YoY.
- FY2024 adjusted EPS guidance raised to $13.05-$13.15; organic revenue growth guidance 5.0%-5.25%.
- Announced agreement to acquire Edwards Lifesciences' Critical Care Product Group for $4.2B.